TMS (Transcranial Magnetic Stimulation)

TMS (transcranial magnetic stimulation, an in-office procedure where a magnetic coil sits against the side of your head and pulses a magnetic field into a specific spot on your brain) is what we offer when you’ve tried two or three antidepressants and you’re still not okay. The magnetic pulses induce small electrical currents in the underlying brain tissue, which over time appears to wake up circuitry that’s been underactive in depression. You stay awake during the session, you can read or watch TV, you drive yourself home after. No anesthesia, no IV, no after-effects worth mentioning beyond a little scalp soreness.

It’s FDA-cleared for major depression that hasn’t responded to one antidepressant, which describes most patients at some point in their treatment journey if they’ve been at it long enough. Newer protocols are also cleared for OCD (obsessive-compulsive disorder), smoking cessation, and migraine. The depression indication is by far the most common use and is what almost every TMS conversation is about.

How you end up here

You don’t start with TMS. Insurance won’t cover it unless you’ve already tried at least one or two antidepressants and either didn’t respond to them or couldn’t tolerate the side effects. So the typical path looks something like this: SSRI (the standard first-line antidepressant family, drugs like Lexapro or Zoloft) for twelve weeks, partial or no response, switch to a different SSRI or SNRI (a related antidepressant family that hits norepinephrine in addition to serotonin) for twelve weeks, partial or no response, and now you’re sitting in front of somebody talking about TMS or augmentation strategies or ketamine. Insurance usually wants documentation of the failed trials before they’ll authorize TMS.

The reason TMS isn’t first-line isn’t that it doesn’t work. It’s that it’s expensive, time-consuming, and requires you to come into an office five days a week for six weeks. SSRIs are cheap and convenient. The system starts with the cheap convenient thing, which is reasonable from a population-level cost standpoint and frustrating if you’re the individual patient who’s going to spend six months on the wrong-for-you medications before the system lets you try the procedure that might actually work.

What a session feels like

You sit in a chair that looks like a fancy dentist’s chair. The technician fits a coil against the side of your head, lined up with a target spot they mapped on your first session. Then the machine starts pulsing. Each pulse feels like a sharp tap, sometimes like a woodpecker on your skull, sometimes more like a hard finger flick. It’s not painful for most patients but it’s not comfortable either. Imagine somebody flicking your scalp pretty hard, rhythmically, for 20 to 40 minutes.

The most common side effect is scalp pain at the treatment site, which usually fades by week two as the area gets used to it. Some patients get a mild headache after the first few sessions that goes away with Tylenol. The serious side effect, which is genuinely rare, is a seizure. The risk is in the range of one in 30,000 sessions, which is the kind of risk you mention because you’re supposed to, not because it’s likely to be a factor. People with active seizure disorders or metallic implants near the treatment site need to talk through the screening more carefully, but for most people the seizure risk is essentially theoretical.

You don’t feel anything mood-related during the session itself. The treatment effect builds slowly over weeks. Most responders start noticing something in week two or three. Some don’t notice until week four or five, which is frustrating but normal. The standard course is 36 sessions, five days a week for six weeks, plus a taper of three to six more sessions over the following weeks. The taper matters because the response curve doesn’t just plateau, it keeps building for a few weeks after the dense protocol ends.

Who it works for

The response rates depend on whose data you’re reading, but in real-world treatment-resistant depression, roughly half the patients sent to TMS get a meaningful response, and about a third get to full remission. That’s better than another medication trial at this point in the journey, which is most of the argument for it. By the time you’ve failed two or three antidepressants, your odds on the next one are getting worse, not better, and the procedure is offering a different mechanism instead of another flavor of the same one.

It works best for patients whose depression is more melancholic, more biological, less driven by ongoing life stressors. If your job is killing you and your marriage is on fire and you haven’t slept in three months, TMS may help but the life stuff is going to need addressing too. TMS isn’t a substitute for therapy when therapy is what’s needed and it isn’t a substitute for changing the actual situation when the situation is the bottleneck. The procedure works on the brain, not on whatever’s outside it that the brain is reacting to.

The insurance reality

Almost all major insurance now covers TMS for treatment-resistant depression, which is genuinely a recent development. Five years ago this was a much harder conversation. The prior authorization process is its own miserable adventure but most clinics handle the paperwork for you. You’ll need documentation of two failed antidepressant trials at adequate doses for adequate durations, ideally from different drug classes. If you’ve also tried therapy that’s documented, that helps the case.

Out of pocket, TMS runs somewhere between $8,000 and $15,000 for a full course, depending on the clinic. With insurance you’re usually on the hook for whatever copays and deductibles apply, which can still add up to a couple thousand dollars by the end of the protocol. Worth asking up front before you start so you can plan around the cost instead of finding out at session twenty.

The pattern that walks in the door

The kind of patient who ends up on TMS is usually somebody who’s been depressed for a year or two, has tried Lexapro and Wellbutrin and Effexor and maybe an augmentation strategy with lithium or low-dose Abilify, and is sitting at maybe 40% better. Functional but not really functional. Still working some days, not working other days. Still not sleeping right. Still not wanting to leave the house most of the time. The honest conversation usually starts with the patient saying some version of “I’ve tried everything and nothing has really worked,” and the honest response is that the medication ladder isn’t actually exhausted yet, but adding another antidepressant is going to keep producing the same shape of result.

The TMS conversation is the offer to try a different mechanism instead of another flavor of the same one. Six weeks of daily commute, 20 to 40 minutes per session. Most patients are annoyed about the schedule for the first week or two. Around week three the spouse starts noticing something. Around week five the patient himself notices something, usually something small first like waking up hungry for breakfast for the first time in a year, or noticing he’s actually listening to the radio in the car instead of staring through the windshield. By the end of the protocol most responders are back to a functional version of themselves, the kind of functional they hadn’t been in two years.

What’s nice to hear about it

TMS doesn’t make you feel like you’re on a medication. There’s no fog, no flatness, no sexual side effects, no weight gain, no blood draws. You sit in a chair five days a week for six weeks, and somewhere in the middle of the protocol the depression starts lifting. That’s the entire side-effect conversation for most patients. The scalp soreness fades, the mild headaches resolve, and the work is just showing up to the chair.

The other thing that doesn’t get said enough is that TMS doesn’t replace your antidepressant. You stay on whatever you’ve been taking, the TMS layers on top, and a lot of patients end up on a more sustainable medication regimen afterward because the procedure handled the floor and the medication is just maintaining. Some patients do eventually come off all medications once they’ve been stable post-TMS for a year or two. Others stay on a maintenance dose of something. Both are fine. The TMS isn’t a one-shot cure, it’s a high-yield intervention that buys you a foundation the medication couldn’t quite build on its own.

The system starts with the cheap convenient thing. TMS is what’s there when the cheap convenient thing didn’t work.

What not to expect

Don’t expect a magic switch. Most responders describe the change as gradual, more like fog lifting over weeks than like waking up one morning fixed. A few guys do have a more dramatic response, but that’s not the common pattern. If you’re week four and nothing’s happening, that’s still within normal range. If you’re week six and absolutely nothing has shifted, the prescriber may try a different protocol or call it a non-response and pivot to something else.

Don’t stop your antidepressant when you start TMS unless that’s been discussed with whoever’s running your medication management. TMS layers on top of medication, it doesn’t replace it during the protocol. Some patients do come off meds eventually once they’ve been stable post-TMS for a while, but that’s a separate conversation later and not something to act on in the middle of the six-week course.

Where I land on it, and where you land is up to you

If you’ve failed two or three antidepressants and you’re still not where you want to be, TMS is one of the better options on the table, often better than the next medication trial. The honest take is that the response rate is solid, the side-effect profile is mild, and the main barrier is the schedule. If you can’t get yourself to the clinic five days a week for six weeks, the procedure isn’t going to work because you won’t finish it. That’s the real screening question, more than insurance or response prediction. Can you keep the appointment.

If the answer is yes and you’re sitting at partial response after multiple medication trials, the conversation is short. I’m a provider, not a parent. The honest take goes on the table and the decision is yours. Most guys who do TMS for treatment-resistant depression don’t regret it, even the ones whose response was modest, because they finally found out whether the procedure was going to do anything for them instead of wondering for the next decade.

Bottom line

If you’ve tried a couple of antidepressants and you’re still depressed, TMS is one of the better options on the table. Six weeks of daily appointments is a real commitment, but the response rate is solid and the side-effect profile is mild. Most insurance covers it now, which is a meaningful change from a few years ago. The hardest part is the logistics of getting yourself to the clinic five days a week when you’re depressed and motivation is the exact thing that’s broken. If you can solve the logistics, the procedure tends to do the rest.

Sources

1. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012;29(7):587-596. PMID 22689344.
2. Berlim MT, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014;44(2):225-239. PMID 23507264.
3. Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet. 2018;391(10131):1683-1692. PMID 29726344.